+1 858 550 6117 rbains@cooley.com
Raj Bains represents public and privately-held companies in corporate and securities matters, including private financings, public offerings, mergers and acquisitions, SEC reporting and corporate governance.
Download full bio
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company
VelosBio Agrees to Sell to Merck for $2.75 Billion
Forbius Agrees to Sell to Bristol Myers Squibb
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
Synthorx to Sell to Sanofi for $2.5 Billion
Mergers & Acquisitions
Public Companies
Venture Capital
Capital Markets
Emerging Companies
Life Sciences
Beach activities
Playing with my dog
Football
University of San Diego School of LawJD, cum laude
University of California, IrvineBA, Criminology, Law and Society
California
VelosBio Agrees to Sell to Merck for $2.75 Billion November 9, 2020
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company October 28, 2020
Forbius Agrees to Sell to Bristol Myers Squibb August 25, 2020
View all
+1 858 550 6117 office rbains@cooley.com
4401 Eastgate MallSan Diego, CA 92121-1909